---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-010105"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:38:21.614116+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences awards CTO Darrin Uecker 100,000 RSUs for AFib product development

## Summary
- Restricted stock units cover 100,000 shares of common stock, par value $0.001.
- Grant vests in full on third anniversary of March 23, 2026 grant date.
- Award made under Amended and Restated 2017 Equity Incentive Plan.
- Compensation Committee granted for continued leadership in atrial fibrillation treatment product development.

## SEC filing metadata
- accession: 0001437749-26-010105
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926010105/0001437749-26-010105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926010105/plse20260327_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-010105
- JSON: https://secwatch.observer/filing/0001437749-26-010105.json
- Plain text: https://secwatch.observer/filing/0001437749-26-010105.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.